Women’s Health Questionnaires

Flo Health and Mayo Clinic Build a 16-Item Perimenopause Scale

Flo Health and Mayo Clinic clinicians created ‘Peri-SS,’ a validated perimenopause questionnaire that gives women a more precise way to log changing symptoms than older menopause scales built around postmenopausal groups. The 16-item format supports Flo’s in-app ‘Peri Score’ and is built for both clinical research and digital self-tracking.

Its validation study surveyed U.S. women ages 35 to 59. A 30-day recall window makes room for the stop-start nature of perimenopause, and the scale includes symptoms like weight changes and digestive issues that older options can miss.

Flo Health shows how a 16-item format can turn a hard-to-describe life stage into a repeatable digital check-in, giving women’s health apps a sturdier basis for longitudinal tracking and symptom education, while linking the scale to Flo’s Peri Score moves perimenopause support toward a standardized product layer inside consumer health platforms rather than a one-time questionnaire.

Image Credit: Flo Health Inc.

Validated Symptom Scoring
Clinically tested questionnaires create room for consumer health platforms to deliver more credible, repeatable tracking tools for complex life-stage symptoms.
Perimenopause Personalization
Digital scoring systems tailored to midlife hormonal changes highlight opportunities for more precise education, triage, and longitudinal support in women’s health.
Research-backed Self-tracking
Validated in-app assessments bridge clinical research and everyday wellness behavior, opening new pathways for health apps to become trusted data sources.

Sectors Adopting This

Women’s Health
Standardized perimenopause measurement strengthens the foundation for products that address underserved midlife health needs with greater specificity.
Digital Health
App-based clinical scales introduce new product layers where symptom logging, education, and care navigation can be integrated into daily user experiences.
Clinical Research
Consumer-generated symptom data from validated tools expands the potential for longitudinal studies that better reflect real-world patient experiences.
SCORE
4.7 out of 10
GENDER
10% Men90% Women
MARKETTop markets: North America
GENERATION
  • Gen Z
  • Gen Alpha
  • Millennial (primary audience)
  • Gen X (primary audience)
POPULARITY
Popularity 16%
Activity 26%
Freshness 99%